Trade Summary

2 days ago, Ceesay Abraham, serving as Chief Executive Officer at Rapport Therapeutics, Inc. (RAPP), sold 8,220 shares at $39.83 per share, for a total transaction value of $327,397.72. Following this transaction, Ceesay Abraham now holds 548,027 shares of RAPP.

This sale represents a 1.48% decrease in Ceesay Abraham's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 4:05 PM ET, 2 days after the trade was made.

Rapport Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.